The development of intelligent endoprosthesis with automatic early detection of potential failure.
Public support
Provider
Technology Agency of the Czech Republic
Programme
Programme of applied research and experimental development ALFA
Call for proposals
ALFA 4 (STA02014TA04)
Main participants
ProSpon, spol. s r.o.
Contest type
VS - Public tender
Contract ID
2014TA04010879
Alternative language
Project name in Czech
Vývoj inteligentních endoprotéz se včasnou automatickou detekcí možného selhání.
Annotation in Czech
Cílem tohoto projektu je návrh inteligentní endoprotézy s automatickou detekcí infekce, opotřebení, destrukce apod., on-line přenosem této informace k ošetřujícímu lékaři a možností aktivace podpůrných léčebných procesů.
Scientific branches
R&D category
AP - Applied research
CEP classification - main branch
FI - Traumatology and orthopaedics
CEP - secondary branch
EI - Biotechnology and bionics
CEP - another secondary branch
FS - Medical facilities, apparatus and equipment
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
20601 - Medical engineering<br>20602 - Medical laboratory technology (including laboratory samples analysis; diagnostic technologies) (Biomaterials to be 2.9 [physical characteristics of living material as related to medical implants, devices, sensors])<br>20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>30211 - Orthopaedics<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics
Completed project evaluation
Provider evaluation
V - Vynikající výsledky projektu (s mezinárodním významem atd.)
Project results evaluation
The project succeeded with excellent results. Achieved goals were reached, which they agreed on and assessors with detailed knowledge of the topic of endoprosthesis. They have been achieved functional and utility pattern outputs in the area of 3 applications: artificial a hip joint, an artificial knee joint and an infected hip spacer replacements with the possibility of telemetry information in case of implant failure.
Solution timeline
Realization period - beginning
Jul 1, 2014
Realization period - end
Dec 31, 2017
Project status
U - Finished project
Latest support payment
Feb 28, 2017
Data delivery to CEP
Confidentiality
C - Předmět řešení projektu podléhá obchodnímu tajemství (§ 504 Občanského zákoníku), ale název projektu, cíle projektu a u ukončeného nebo zastaveného projektu zhodnocení výsledku řešení projektu (údaje P03, P04, P15, P19, P29, PN8) dodané do CEP, jsou upraveny tak, aby byly zveřejnitelné.
Data delivery code
CEP18-TA0-TA-U/16:1
Data delivery date
Nov 6, 2018
Finance
Total approved costs
29,371 thou. CZK
Public financial support
19,074 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
10,298 thou. CZK